Gastrointestinal Cancer News

Adults who underwent surgery for most cancer types had a significantly higher incidence of suicide compared with the U.S. general population, results of a retrospective study in JAMA Oncology showed.

Healio will present its second annual Disruptive Innovators Awards for oncology/hematology this spring.

Cost-effectiveness analysis revealed limited differences between laparoscopic vs. open gastrectomy at 1-year follow-up among a cohort of Dutch patients with gastric cancer, according to results published in JAMA Surgery.

Geneoscopy Inc. announced favorable results from its CRC-PREVENT trial, which assessed noninvasive, stool-based, at-home screening for colorectal cancer and advanced adenomas.

Neoadjuvant treatment with immune checkpoint inhibitors for colorectal cancer induced clinical responses that helped delay or prevent surgical resection, results of a study in Journal of the National Comprehensive Cancer Network showed.

The FDA announced several regulatory actions the past few weeks.

The FDA has granted breakthrough device designation to Burning Rock’s OverC multicancer blood test for early detection of esophageal, liver, lung, ovarian and pancreatic cancers, according to a company press release.

Data suggest reducing sodium limits on prepackaged foods to comply with new WHO benchmarks could prevent nearly 1,800 deaths and thousands of related diseases on a population level in Australia per year, researchers reported.

Response rates to investigational therapies evaluated in NCI-sponsored phase 1 trials for solid cancers have doubled over the past 2 decades, according to study results published in The Lancet.

Multiomic analysis has provided new insights into the genetics of colorectal cancer and how genetic variants contribute to disease risk and development.